Hereditary spastic paraparesis has been associated with many conditions including optic atrophy, retinopathy, extrapyramidal disease, amyotrophy, dementia, ataxia, mental retardation, deafness, ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023. Net product sales of CAPLYTA were $199.2 million for the fourth quarter of ...